SC Health Corporation (SCPE) Stock Analysis
DELISTED 2021
What happened to SC Health Corporation (SCPE) stock?
SC Health Corporation (SCPE) no longer trades on public markets. It was delisted in August 2021. The figures below are historical and are not a current quote.
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
SC Health Corporation (SCPE) trades at $15.84. SC Health Corporation is a blank check company focused on identifying and merging with a healthcare business in the Asia Pacific region. Sector: Financial services.
Last analyzed: Mar 17, 2026Analyst Coverage for SCPE: SCPE does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates SCPE against Financial Services peers across nine fundamental dimensions and assigns a neutral fundamental signal based on the underlying data.
SC Health Corporation (SCPE) Financial Services Profile
SC Health Corporation (SCPE) is a special purpose acquisition company (SPAC) targeting the healthcare sector within the Asia Pacific region, currently seeking a merger, share exchange, or acquisition to establish its operational business. The company has no revenue and is pre-business combination.
What Is the Investment Thesis for SCPE?
SC Health Corporation presents a speculative investment opportunity tied to its ability to identify and merge with a promising healthcare business in the Asia Pacific region. As a SPAC, SCPE's value is currently derived from the potential of a future acquisition. Key value drivers include the management team's experience in deal-making and the attractiveness of the target company they ultimately select. The timeline for identifying and completing a merger is uncertain, and the success of the investment is contingent on the performance of the acquired business. The current P/E ratio is -330.91, reflecting the absence of earnings. Investors should carefully consider the risks associated with SPAC investments, including the possibility of dilution and the uncertainty surrounding the target company's future performance.
Based on FMP financials and quantitative analysis
SCPE Key Highlights
SC Health Corporation operates as a blank check company with no current revenue generation.
- The company's focus is on identifying a target within the healthcare sector in the Asia Pacific region.
- SCPE's P/E ratio is -330.91, reflecting its pre-revenue status.
- SC Health Corporation has no dividend yield, consistent with its stage of development as a SPAC.
- The company's success is entirely dependent on the successful identification and merger with a suitable target company.
Who Are SCPE's Competitors?
SCPE is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| AONC American Oncology Network, Inc. | $11.12 | +0.00% | $325M | 50 |
| GVCI Green Visor Financial Technology Acquisition Corp. I | $10.59 | -0.19% | $265M | 44 |
| IGNY Ignyte Acquisition Corp. | $13.05 | +14.57% | $262M | 43 |
| RDZN Roadzen, Inc. | $1.55 | +2.65% | $131M | — |
| AGGI Allied Energy, Inc. | $2.25 | +32.24% | $45.4B | 61 |
| GSHN Gushen, Inc. | $22.70 | +2.71% | $9.32B | 61 |
| IVAN Ivanhoe Capital Acquisition Corp. | $7.68 | -2.17% | $2.69B | 64 |
| APXTW Apex Treasury Corporation | $0.35 | -5.41% | $1.89B | 66 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are SCPE's Key Strengths?
Experienced management team
- Focus on high-growth Asia Pacific healthcare market
- Potential for significant value creation through successful merger
- Access to public market capital
What Are SCPE's Weaknesses?
No current revenue or operations
- Dependence on identifying and acquiring a suitable target
- Uncertainty surrounding the target company's future performance
- Potential for dilution
What Could Drive SCPE Stock Higher?
Announcement of a definitive merger agreement with a target company.
- Due diligence and negotiations with potential target companies.
- Monitoring of market trends and opportunities in the Asia Pacific healthcare sector.
What Are the Key Risks for SCPE?
Negative return on equity (-0.6%) — the business is not currently generating profit on shareholder capital.
- Insider selling — insiders were net sellers of roughly $67.6M recently.
- Failure to identify and complete a merger with a suitable target company.
- Dilution of shareholder value through future equity offerings.
- Economic downturn or regulatory changes impacting the healthcare industry.
- Competition from other SPACs seeking merger targets.
What Are the Growth Opportunities for SCPE?
- Successful Merger Completion: SC Health Corporation's primary growth opportunity lies in successfully completing a merger with a high-growth healthcare company in the Asia Pacific region. The Asia Pacific healthcare market is projected to experience substantial growth, driven by factors such as aging populations, rising incomes, and increasing access to healthcare services. A successful merger would provide SC Health Corporation with immediate access to this growing market and position it for long-term value creation. Timeline: Within the next 12-24 months.
- Geographic Expansion within Asia Pacific: Following a successful merger, SC Health Corporation can pursue geographic expansion within the Asia Pacific region. The region encompasses a diverse range of markets with varying levels of healthcare development. By strategically expanding into new markets, SC Health Corporation can tap into additional growth opportunities and diversify its revenue streams. Timeline: 2-3 years post-merger.
- Service Line Expansion: SC Health Corporation can expand its service offerings to cater to a broader range of healthcare needs. This could involve introducing new products or services, expanding into adjacent market segments, or developing innovative healthcare solutions. By diversifying its service lines, SC Health Corporation can enhance its competitive position and capture a larger share of the healthcare market. Timeline: 3-5 years post-merger.
- Technological Innovation: Investing in technological innovation can drive growth and improve efficiency. This could involve adopting new technologies, developing proprietary solutions, or partnering with technology companies to enhance its capabilities. By embracing technological innovation, SC Health Corporation can gain a competitive edge and deliver superior value to its customers. Timeline: Ongoing.
- Strategic Partnerships and Acquisitions: SC Health Corporation can pursue strategic partnerships and acquisitions to accelerate growth and expand its market reach. This could involve partnering with other healthcare providers, technology companies, or research institutions to leverage their expertise and resources. Strategic acquisitions can provide access to new markets, technologies, or customer segments. Timeline: Ongoing.
What Are SCPE's Competitive Advantages?
- Management Team Expertise: The expertise and track record of SC Health Corporation's management team in identifying and executing successful mergers and acquisitions can be a competitive advantage.
- Focus on Asia Pacific Healthcare: Specializing in the Asia Pacific healthcare sector provides a degree of focus and expertise that may not be present in more generalist SPACs.
- First-Mover Advantage: Identifying and securing a merger with a high-potential target company before competitors can create a first-mover advantage.
What Does SCPE Do?
SC Health Corporation is a blank check company, also known as a special purpose acquisition company (SPAC), formed with the singular purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. Founded with the intention of capitalizing on opportunities within the healthcare sector in the Asia Pacific region, SC Health Corporation is actively searching for a suitable target company. The company's strategy involves leveraging the expertise of its management team to identify and evaluate potential acquisition targets, negotiate favorable terms, and ultimately bring a promising healthcare business to the public market. As of the current date, SC Health Corporation has not engaged in any business operations and has not generated any revenue, existing solely as a vehicle for a future business combination. The success of SC Health Corporation hinges on its ability to identify and successfully merge with a target company that offers significant growth potential and value creation opportunities within the dynamic Asia Pacific healthcare landscape. The company's future direction and performance are entirely dependent on the characteristics and performance of the business it ultimately acquires.
What Products and Services Does SCPE Offer?
- SC Health Corporation is a blank check company.
- They are formed to effect a merger or similar business combination.
- Their focus is on the healthcare sector in the Asia Pacific region.
- They seek a target company through share exchange or asset acquisition.
- They aim to bring a private healthcare business to the public market.
- They have not yet engaged in any business operations.
How Does SCPE Make Money?
- SC Health Corporation's business model is centered around identifying and acquiring a private healthcare company.
- They raise capital through an initial public offering (IPO) to fund the acquisition.
- The company's value is derived from the potential of the acquired business.
- They generate returns for investors through the growth and profitability of the merged entity.
What Industry Does SCPE Operate In?
SC Health Corporation operates within the shell company industry, specifically as a special purpose acquisition company (SPAC). The SPAC market has experienced periods of heightened activity and increased scrutiny. These companies offer a streamlined path for private companies to go public, but also carry inherent risks due to their speculative nature. The competitive landscape includes numerous other SPACs actively seeking merger targets across various sectors. SC Health Corporation differentiates itself by focusing on the healthcare sector in the Asia Pacific region, a market with significant growth potential.
Who Are SCPE's Key Customers?
- SC Health Corporation's 'customers' are its investors who purchase shares in the IPO.
- The target company they acquire will have its own customer base, which will vary depending on the specific business.
- Ultimately, the success of SC Health Corporation depends on the satisfaction and loyalty of the acquired company's customers.
Insider Activity
The most recent 12 insider filings for SC Health Corporation break down as 11 sales and 1 purchases. On net that is roughly 5.9M shares disposed (about $67.6M), a signal worth weighing alongside the fundamentals.
Key Financial Metrics
Return on equity for SC Health Corporation stands at -0.6%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -0.6%, showing how much profit it generates from its asset base. A current ratio of 0.22 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is -0.3%, the inverse of the P/E and a quick read on earnings relative to price.
Company Profile
SC Health Corporation operates in the Shell Companies industry within the Financial Services sector. The company is led by CEO Angelo John Coloma. SCPE has traded publicly since 2019.
SCPE Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
Bull Case vs Bear Case
Bull Case
- The community seems optimistic about SCPE's long-term growth prospects based on recent discussions.
- Market perception is shifting positively as SCPE expands its healthcare solutions.
- Recent developments indicate a strengthening market position for SCPE.
Bear Case
- Some insiders sold shares recently, raising concerns despite overall buying activity.
- Community sentiment shows some skepticism about SCPE's ability to maintain its growth rate.
- Market perception is that SCPE faces increasing competition in the healthcare sector.
- Recent market developments have introduced uncertainty about SCPE's future performance.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026
SCPE Latest News
No recent news available for SCPE.
Classification
Industry Shell CompaniesLeadership: Angelo John Coloma
CEO
Angelo John Coloma is the Chief Executive Officer of SC Health Corporation. His background includes experience in the financial services sector, with a focus on investment banking and mergers and acquisitions. He has held various leadership positions in previous companies, where he was responsible for identifying and executing strategic transactions. Mr. Coloma brings a wealth of knowledge and expertise to SC Health Corporation, particularly in the areas of deal structuring, financial analysis, and business development. His experience is expected to be instrumental in guiding SC Health Corporation through the process of identifying and acquiring a suitable target company in the healthcare sector.
Track Record: While specific details on Mr. Coloma's track record within SC Health Corporation are limited due to the company's early stage, his previous roles have involved successful deal execution and value creation. His leadership is focused on identifying a high-growth healthcare business in the Asia Pacific region and completing a merger that will deliver significant returns for investors. The successful completion of a merger will be a key milestone under his leadership.
What Investors Ask About SC Health Corporation (SCPE) — Financial Services
What happened to SC Health Corporation (SCPE) stock?
SC Health Corporation (SCPE) no longer trades on public markets. It was delisted in August 2021. The figures below are historical and are not a current quote.
Can I still buy SCPE shares?
No. SCPE stopped trading on public markets in August 2021, so the shares are not available through a broker. Anything you see quoted for SCPE elsewhere is historical data, not a live market.
Are the figures on this page current?
No. Every number here is the last value recorded before SCPE stopped trading. Nothing on this page updates, and none of it is a current quote.
Why does this page still exist?
Because people still search for what happened to SC Health Corporation. An archived profile that states the delisting plainly is more useful than a dead link — provided it is labelled as history, which is what this page does.
What does SC Health Corporation do?
SC Health Corporation functions as a special purpose acquisition company (SPAC), also known as a blank check company. Its primary objective is to identify and merge with a private company operating within the healthcare sector in the Asia Pacific region. SC Health Corporation raises capital through an initial public offering (IPO) and then seeks a suitable acquisition target.
What do analysts say about SCPE stock?
As a special purpose acquisition company (SPAC) without current operations, traditional analyst coverage of SC Health Corporation (SCPE) is limited. The stock's performance is primarily driven by speculation surrounding potential merger targets and the perceived value of those targets. Investors should conduct their own due diligence and carefully consider the risks associated with SPAC investments.
What are the main risks for SCPE?
The primary risk for SC Health Corporation lies in its ability to identify and successfully merge with a suitable target company within the healthcare sector in the Asia Pacific region. Competition from other SPACs seeking similar targets could drive up acquisition costs or lead to the selection of a less desirable target.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on publicly available sources and may be subject to change.
- AI analysis is pending and may provide further insights in the future.